Literature DB >> 18940295

Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module).

Deborah B Diercks1, Gregg C Fonarow, J Douglas Kirk, Preeti Jois-Bilowich, Judd E Hollander, Jim Edward Weber, Janet Wynne, Roger M Mills, Clyde Yancy, W Franklin Peacock.   

Abstract

Illicit stimulant drug use may have a profound clinical impact in acute decompensated heart failure (ADHF). The chronic use of cocaine and methamphetamine may lead to overt cardiomyopathy and ADHF. The Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM) collected data on patients presenting to emergency departments with ADHF at 83 geographically dispersed hospitals in the United States. This registry was queried to determine the rate of self-reported illicit drug use in emergency department patients presenting with ADHF and compare these patients with those without illicit drug use. The registry enrolled 11,258 patients with ADHF with drug use data from January 2004 to March 2006. Of these patients, 594 (5.3%) self-reported current or past stimulant drug use. Compared with nonusers, these patients were more likely to be younger (median age 49.7 vs 76.1 years), to be African American (odds ratio 11.9, 95% confidence interval 9.8 to 14.4), and to have left ventricular ejection fractions <40% (odds ratio 3.4, 95% confidence interval 2.8 to 4.2). Admitted users had no difference in mortality (adjusted odds ratio 0.83, 95% confidence interval 0.25 to 2.72) compared with nonusers. In conclusion, data from ADHERE-EM suggest that a clinically important percentage of patients with ADHF report the use of illicit stimulant drugs. Although these patients are younger with a greater degree of LV dysfunction, they did not have greater risk-adjusted mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940295     DOI: 10.1016/j.amjcard.2008.06.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

Review 2.  Vascular disease in cocaine addiction.

Authors:  Keren Bachi; Venkatesh Mani; Devi Jeyachandran; Zahi A Fayad; Rita Z Goldstein; Nelly Alia-Klein
Journal:  Atherosclerosis       Date:  2017-03-14       Impact factor: 5.162

3.  Psychostimulant-related deaths among former inmates.

Authors:  Susan Calcaterra; Patrick Blatchford; Peter D Friedmann; Ingrid A Binswanger
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

4.  Is biological aging accelerated in drug addiction?

Authors:  Keren Bachi; Salvador Sierra; Nora D Volkow; Rita Z Goldstein; Nelly Alia-Klein
Journal:  Curr Opin Behav Sci       Date:  2017-02

5.  Improvement in clinical outcomes of patients with heart failure and active cocaine use after β-blocker therapy.

Authors:  Persio D Lopez; Adedoyin Akinlonu; Tuoyo O Mene-Afejuku; Carissa Dumancas; Mohammed Saeed; Eder H Cativo; Ferdinand Visco; Savi Mushiyev; Gerald Pekler
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

6.  Association of modifiable risk factors and left ventricular ejection fraction among hospitalized Native Hawaiians and Pacific Islanders with heart failure.

Authors:  Marjorie K L M Mau; Todd B Seto; Joseph K Kaholokula; Barbara Howard; Robert E Ratner
Journal:  Hawaii J Med Public Health       Date:  2014-12

7.  Hypertensive heart disease associated with methamphetamine abuse.

Authors:  Takatsugu Segawa; Yoh Arita; Nobuyuki Ogasawara; Shinji Hasegawa
Journal:  J Cardiol Cases       Date:  2018-10-30

8.  Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance.

Authors:  Javier E Lopez; Khung Yeo; Gary Caputo; Michael Buonocore; Saul Schaefer
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-11       Impact factor: 5.364

Review 9.  Methamphetamine-associated cardiomyopathy.

Authors:  Sekon Won; Robert A Hong; Ralph V Shohet; Todd B Seto; Nisha I Parikh
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

10.  National trends in psychostimulant-related deaths: 1999-2009.

Authors:  Susan Calcaterra; Ingrid A Binswanger
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.